Economic Analysis of Panitumumab Compared With Cetuximab in
Economic Analysis of Panitumumab Compared With Cetuximab in Patients With Wildtype KRAS Metastatic Colorectal Cancer That Progressed After Standard Chemotherapy Christopher N. Graham, MS, Gregory A. Maglinte, Ph. D, Lee S. Schwartzberg, MD, FACP, Timothy J. Price, MBBS, DHlth. Sc (Medicine), FRACP, Hediyyih N. Knox, MA, Guy Hechmati, MD, MSc, Jonas Hjelmgren, MSc, Beth Barber, Ph. D, Marwan G. Fakih, MD Clinical Therapeutics Volume 38 Issue 6 Pages 1376 -1391 (June 2016) DOI: 10. 1016/j. clinthera. 2016. 03. 023 Copyright © 2016 The Authors Terms and Conditions
Figure 1 Clinical Therapeutics 2016 381376 -1391 DOI: (10. 1016/j. clinthera. 2016. 03. 023) Copyright © 2016 The Authors Terms and Conditions
Figure 2 Clinical Therapeutics 2016 381376 -1391 DOI: (10. 1016/j. clinthera. 2016. 03. 023) Copyright © 2016 The Authors Terms and Conditions
Figure 3 Clinical Therapeutics 2016 381376 -1391 DOI: (10. 1016/j. clinthera. 2016. 03. 023) Copyright © 2016 The Authors Terms and Conditions
Figure 4 Clinical Therapeutics 2016 381376 -1391 DOI: (10. 1016/j. clinthera. 2016. 03. 023) Copyright © 2016 The Authors Terms and Conditions
Figure 5 Clinical Therapeutics 2016 381376 -1391 DOI: (10. 1016/j. clinthera. 2016. 03. 023) Copyright © 2016 The Authors Terms and Conditions
Figure 6 Clinical Therapeutics 2016 381376 -1391 DOI: (10. 1016/j. clinthera. 2016. 03. 023) Copyright © 2016 The Authors Terms and Conditions
- Slides: 7